Nongenotoxic activation of the p53 pathway as a therapeutic strategy for multiple myeloma.
Stühmer T, Chatterjee M, Hildebrandt M, Herrmann P, Gollasch H, Gerecke C, Theurich S, Cigliano L, Manz RA, Daniel PT, Bommert K, Vassilev LT, Bargou RC.
Stühmer T, et al. Among authors: chatterjee m.
Blood. 2005 Nov 15;106(10):3609-17. doi: 10.1182/blood-2005-04-1489. Epub 2005 Aug 4.
Blood. 2005.
PMID: 16081689
Free article.